Evidence map›Paper›PMID 39711253›Full record

ArticleVeterinary and comparative oncology2025

Precision in Parsing: Evaluation of an Open-Source Named Entity Recognizer (NER) in Veterinary Oncology.

Christopher J Pinard, Andrew C Poon, Andrew Lagree, Kuan-Chuen Wu, Jiaxu Li, William T Tran

Abstract read
In one paragraph

Article in Veterinary and comparative oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christopher J PinardDepartment of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.ORCID https://orcid.org/0000-0003-1311-5467
Andrew C PoonVCA Mississauga Oakville Veterinary Emergency Hospital, Mississauga, Ontario, Canada.
Andrew LagreeRadiogenomics Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Kuan-Chuen WuANI.ML Research, ANI.ML Health Inc., Toronto, Ontario, Canada.
Jiaxu LiRadiogenomics Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
William T TranRadiogenomics Laboratory, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrating Artificial Intelligence (AI) through Natural Language Processing (NLP) can improve veterinary medical oncology clinical record analytics. Named Entity Recognition (NER), a critical component of NLP, can facilitate efficient data extraction and automated labelling for research and clinical decision-making. This study assesses the efficacy of the Bio-Epidemiology-NER (BioEN), an open-source NER developed using human epidemiological and medical data, on veterinary medical oncology records. The NER's performance was compared with manual annotations by a veterinary medical oncologist and a veterinary intern. Evaluation metrics included Jaccard similarity, intra-rater reliability, ROUGE scores, and standard NER performance metrics (precision, recall, F1-score). Results indicate poor direct translatability to veterinary medical oncology record text and room for improvement in the NER's performance, with precision, recall, and F1-score suggesting a marginally better alignment with the oncologist than the intern. While challenges remain, these insights contribute to the ongoing development of AI tools tailored for veterinary healthcare and highlight the need for veterinary-specific models.

Indexed as

Artificial IntelligenceMedical OncologyNatural Language ProcessingNeoplasmsVeterinary MedicineAnimalsHumansReproducibility of Results

Identifiers

PMID39711253
PMCPMC11830456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.